Skip to content

PALATIN TECHNOLOGIES INC

PTN · XNAS

CIK 911216fmd_1PVT0GHHHFXX7S8W9PNHAMP34GManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jul 01, 2009 to Jun 30, 2026, 65 periods

Income Statement · Annual · Millions · USD
Line itemFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Total revenues6767600(0)15409
Cost of revenue–––00000––
Gross profit–––0(0)144––
Research and development33331514132123221512
Selling, general and administrative–––––1715128–
Total operating expenses414125(24)333837271722
Operating income262636(24)(33)(37)(32)(22)(17)(9)
Interest expense1100000000
Interest and investment income00010–––––
Other non-operating income (expense)(1)(1)01(0)04(7)00
Income before taxes–––––(36)(32)–––
Income tax expense0000–0(5)(30)(17)(8)
Net income from continuing operations–––––(36)(28)–––
Net income252536(22)(34)(36)(24)(30)(17)(8)
PALATIN TECHNOLOGIES INC (PTN) financial statements · FinancialMD